Valuation: Yuhan Corporation

Capitalization 6,956B 4.73B 4.01B 3.69B 3.49B 6.51B 441B 6.63B 43.44B 17B 212B 17.76B 17.38B 751B P/E ratio 2026 *
44.3x
P/E ratio 2027 * 31.1x
Enterprise value 6.73B 4.58M 3.88M 3.57M 3.37M 6.3M 426M 6.41M 42.03M 16.45M 205M 17.18M 16.82M 727M EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.48x
Free-Float
67.64%
Yield 2026 *
0.55%
Yield 2027 * 0.56%
1 day+1.63%
1 week+2.41%
Current month-1.27%
1 month-5.74%
3 months-14.29%
6 months-22.00%
Current year-16.73%
1 week 91,200
Extreme 91200
94,700
1 month 90,900
Extreme 90900
101,200
Current year 90,900
Extreme 90900
115,900
1 year 90,900
Extreme 90900
136,400
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 61 2020-02-29
Change 5d. change 1-year change 3-years change Capi.($)
+1.63%+2.41%-17.61%+68.00% 4.6B
+3.14%+8.57%-0.85%-29.11% 57.51B
+0.92%-4.33%+16.07%-18.69% 8.19B
+0.49%+5.83%+9.64%+88.81% 7.94B
+1.52%+5.36%-2.72%+31.84% 5.2B
+0.32%-1.67%+58.58%+38.96% 2.88B
+2.91%+0.88%-17.26%-37.07% 2.69B
+0.88%+4.16%+27.39%+37.49% 2.45B
-0.20%-6.93%-2.87%-24.13% 1.93B
+2.56%+2.86%+83.48%-1.03% 1.94B
Average +1.41%-0.07%+15.39%+15.51% 9.53B
Weighted average by Cap. +2.33%+5.01%+4.29%-6.17%

Financials

2026 *2027 *
Net sales 2,367B 1.61B 1.36B 1.26B 1.19B 2.22B 150B 2.26B 14.78B 5.78B 72B 6.04B 5.91B 256B 2,663B 1.81B 1.53B 1.41B 1.33B 2.49B 169B 2.54B 16.63B 6.51B 81B 6.8B 6.65B 288B
Net income 171B 117M 98.77M 90.98M 85.89M 160M 10.85B 163M 1.07B 419M 5.21B 437M 428M 18.51B 240B 163M 138M 127M 120M 224M 15.18B 228M 1.5B 586M 7.29B 612M 599M 25.89B
Net Debt -225B -153M -130M -120M -113M -211M -14.27B -215M -1.41B -551M -6.85B -575M -563M -24.34B -341B -232M -196M -181M -171M -319M -21.58B -325M -2.13B -833M -10.37B -870M -852M -36.82B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,067
Date Price Change Volume
26-04-14 93,600.00 +1.63% 185,440
26-04-13 92,100.00 -0.86% 136,295
26-04-10 92,900.00 -0.96% 176,406
26-04-09 93,800.00 -0.42% 203,826
26-04-08 94,200.00 +3.06% 205,545
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
93,600.00KRW
Average target price
144,157.89KRW
Spread / Average Target
+54.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock